Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
- PMID: 37051007
- PMCID: PMC10085351
- DOI: 10.7759/cureus.36011
Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Abstract
Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mellitus (DM) is linked with obesity, metabolic syndrome, and lifestyle changes, where adipokines play an important role. Zinc alpha 2 glycoprotein (ZAGP) is an adipokine, and in this study, it was assessed as a potential biomarker for early DN as well as its progression. Materials and methods This study was a cross-sectional case-control study conducted at a tertiary hospital in northern India. T2DM patients aged 18-65 years old were included in the study and were divided into four groups based on their albuminuria level. This study included 160 participants, with 40 participants in each group. Group I included healthy volunteers, while Groups II, III, and IV were normoalbuminuric, microalbuminuric, and macroalbuminuric diabetic patients, respectively. The groups were evaluated for demographic variables, biochemical parameters, urine albumin-creatinine ratio (UACR), and serum ZAGP. Data between the groups were compared statistically. Results This study included 160 participants, with 40 participants in each group. There was a significant difference between the groups based on the serum ZAGP (p<0.001). Serum ZAGP was significantly negatively correlated with serum creatinine, glycosylated hemoglobin (HbA1c), serum cholesterol, serum triglyceride, low-density lipoprotein (LDL) cholesterol, and UACR. ZAGP was positively correlated with the estimated glomerular filtration rate (eGFR). Conclusion The present study showed that ZAGP was an early biomarker of diabetic nephropathy, and its value decreased as DN progressed. It also suggested that ZAGP, an adipokine, has an anti-inflammatory mechanism of action and its depletion worsens the disease.
Keywords: adipokine; anti-inflammatory; egfr; glycated hemoglobin (hba1c); microalbuminuria.
Copyright © 2023, Sonkar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.J Bras Nefrol. 2019 Oct-Dec;41(4):509-517. doi: 10.1590/2175-8239-JBN-2018-0200. J Bras Nefrol. 2019. PMID: 30897192 Free PMC article.
-
Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.J Int Med Res. 2016 Apr;44(2):278-86. doi: 10.1177/0300060515601699. Epub 2016 Feb 8. J Int Med Res. 2016. PMID: 26857862 Free PMC article.
-
The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.Diabetes Metab Res Rev. 2015 Oct;31(7):717-24. doi: 10.1002/dmrr.2659. Epub 2015 Jun 25. Diabetes Metab Res Rev. 2015. PMID: 25952368
-
Investigating Interleukin-6 Levels in Type 2 Diabetes Mellitus Patients With and Without Diabetic Nephropathy.Cureus. 2024 Aug 16;16(8):e67014. doi: 10.7759/cureus.67014. eCollection 2024 Aug. Cureus. 2024. PMID: 39280507 Free PMC article.
-
Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.J Investig Med. 2021 Aug;69(6):1189-1195. doi: 10.1136/jim-2021-001785. Epub 2021 Apr 16. J Investig Med. 2021. PMID: 33863755
Cited by
-
Association Between Dietary Zinc Intake and Increased Renal Function in US Adults.Biol Trace Elem Res. 2024 Sep;202(9):3871-3885. doi: 10.1007/s12011-023-03969-6. Epub 2023 Nov 28. Biol Trace Elem Res. 2024. PMID: 38015328
-
The Associations between Asprosine, Clusterin, Zinc Alpha-2-Glycoprotein, Nuclear Factor Kappa B, and Peroxisome Proliferator-Activated Receptor Gamma in the Development of Complications in Type 2 Diabetes Mellitus.J Clin Med. 2024 Oct 14;13(20):6126. doi: 10.3390/jcm13206126. J Clin Med. 2024. PMID: 39458076 Free PMC article.
-
Identification of α2-macroglobulin as a biomarker for type 2 diabetes in human serum.Front Endocrinol (Lausanne). 2025 May 23;16:1534490. doi: 10.3389/fendo.2025.1534490. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40487757 Free PMC article.
References
-
- The global burden of diabetic kidney disease: time trends and gender gaps. Thomas B. Curr Diab Rep. 2019;19:18. - PubMed
-
- Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers. Hussain S, Jamali MC, Habib A, Hussain MS, Akhtar M, Najmi AK. Clin Epidemiology Glob Health. 2021;9:2–6.
-
- Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes. Klimontov VV, Korbut AI. Diabetes Metab Syndr. 2019;13:474–479. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous